Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial. - Budde LE; Zhang H; Kim WS; Maruyama D; Rego EM; Norasetthada L; Hong H; Ozcan M; Jeon YW; Leão Cordeiro de Farias D; Fogliatto LM; Pavlovsky A; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)